Monte Rosa Therapeutics announced data for MRT-8102, its NEK7-directed molecular glue degrader, showing positive impact on biomarkers linked to atherosclerotic cardiovascular disease
BiotechTV - News
00:00
Outro
The host thanks Markus Warmuth for discussing Monte Rosa’s pipeline, MRT-8102, and future molecular glue developments.
Play episode from 20:28
Transcript
